hotspot -WSS

hotspot

author：knowledge 2025-09-27 12:56:20 - browse：282

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Brain technologies pose threats that are all too real, experts warn

WSS

Empower primary care with adequate payments and technology

Deliver public health messages at the right time

GSK’s asthma push continues as drug succeeds in Phase 3 trials

FDA gives detailed accounting of AI

Beam Therapeutics to lay off 20% of its staff, re

2023 STAT Wunderkinds: get to know the winners

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Walensky prepares to leave CDC — and Congress — behind

HHS leader on health, climate change and biopharma emissions

Medicare details structure of new drug price negotiation program

BIO to announce reorganization, senior leaders expected to depart

BioMarin wins approval for gene therapy to treat hemophilia A

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Heart attack and stroke risk calculators need revising

As health system earnings go up, health insurance stocks go down

Jerome Adams on the need for new antivirals for Covid

The EU Joint Clinical Assessment needs to live up to its promise

explore

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Warren pushes Witty on UnitedHealth's control over physicians

Solve the antibiotic resistance crisis with preventive drugs

Crowdfunding for medical bills sidesteps core problem, author says

Brain MRIs reveal impact of 'toxic stress' on Black children

How climate

focus

focus

knowledge

leisure time